|
|
|
| Trends in incidence and mortality of colorectal cancer in Nantong City from 2013 to 2022 |
| CHEN Mingrui, LIN Ling, CHU Chu, HUANG Jie, HAN Yarong, CAI Bo, HAN Yingying
|
| Nantong Center for Disease Control and Prevention, Nantong, Jiangsu 226007, China |
|
|
|
|
Abstract Objective To investigate trends in incidence and mortality of colorectal cancer in Nantong City, Jiangsu Province from 2013 to 2022. Methods Data on incidence and mortality of colorectal cancer from 2013 to 2022 in Nantong City were collected through the Nantong City cancer registry. The crude incidence, crude mortality, average age at onset, and average age at death of colorectal cancer were calculated. Chinese population-standardized incidence, Chinese population-standardized mortality, Chinese population-standardized average age at onset and Chinese population-standardized average age at death were calculated using the age structure of the standard population from the Fifth National Population Census in 2000. Trends in incidence and mortality of lung cancer from 2013 to 2022 were evaluated using average annual percent change (AAPC). Trends in the Chinese population-standardized average age at onset and Chinese population-standardized average age at death of lung cancer from 2013 to 2022 were evaluated using the linear regression model. Results From 2013 to 2022, the crude incidence and Chinese population-standardized incidence of colorectal cancer in Nantong City increased from 33.63/105 and 16.05/105 to 53.82/105 and 19.62/105, respectively, showing upward trends (AAPC=5.665% and 2.467%, both P<0.05). The crude mortality increased from 15.99/105 in 2013 to 25.65/105 in 2022, also showing an upward trend (AAPC=5.514%, P<0.05), while no statistically significant trend was found in the Chinese population-standardized mortality (P>0.05). The Chinese population-standardized incidence of colorectal cancer showed upward trends in both males and females (AAPC=2.666% and 1.790%, both P<0.05). The Chinese population-standardized mortality showed an upward trend in males (AAPC=1.966%, P<0.05), but no statistically significant trend was found in females (P>0.05). The crude incidence of colorectal cancer in the groups aged 40-<50 years, 50-<60 years, 60-<70 years, 70-<80 years, and ≥80 years showed upward trends (AAPC=4.045%, 2.833%, 2.300%, 1.948%, and 1.775%, all P<0.05), and the crude mortality in the group aged ≥80 years showed an upward trend (AAPC=3.240%, P<0.05). The average age at onset of colorectal cancer increased at an annual average of 0.156 years (P<0.05), while the trend in the Chinese population-standardized average age at onset was not statistically significant (P>0.05). The average age at death and the Chinese population-standardized average age at death increased at an annual average of 0.325 and 0.153 years, respectively (both P<0.05). Conclusions From 2013 to 2022, both the crude incidence and mortality of colorectal cancer in Nantong City showed upward trends. Males and individuals aged ≥40 years faced a higher risk of both incidence and mortality. It is recommended to implement comprehensive prevention and control measures targeting these high-risk populations to reduce the burden of colorectal cancer.
|
|
Received: 04 September 2025
Revised: 22 September 2025
Published: 23 October 2025
|
|
|
|
|
|
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53.
[3] ZENG H M,CHEN W Q,ZHENG R S,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):555-567.
[4] National Cancer Institute,USA.Cancer statistics explorer network[EB/OL].[2025-09-22].https://seer.cancer.gov/statistics-network/.2025.07.02.
[5] Japan Cancer Center.Cancer statistics in Japan-2023[EB/OL].[2025-09-22].https://ganjoho.jp/public/qa_links/report/statistics/2023_en.html.2023.03.31.
[6] 韩仁强,缪伟刚,俞浩,等.2020年江苏省恶性肿瘤发病和死亡现状分析[J].江苏预防医学,2024,35(5):568-574.
HAN R Q,MIAO W G,YU H,et al.Incidence and mortality analysis of cancers in Jiangsu Province in 2020[J].Jiangsu J Prev Med,2024,35(5):568-574.(in Chinese)
[7] 曾红梅,曹毛毛,郑荣寿,等.2000—2014年中国肿瘤登记地区肝癌发病年龄变化趋势分析[J].中华预防医学杂志,2018,52(6):573-578.
ZENG H M,CAO M M,ZHENG R S,et al.Trend analysis of age of diagnosis for liver cancer in cancer registry areas of China,2000-2014[J].Chin J Prev Med,2018,52(6):573-578.(in Chinese)
[8] 国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016.
National Cancer Center.Chinese guideline for cancer registration(2016)[M].Beijing:People's Medical Publishing House,2016.(in Chinese)
[9] 南通市统计局.南通市第七次全国人口普查公报(第四号)——人口年龄构成情况[EB/OL].[2025-09-22].https://tjj.nantong.gov.cn/ntstj/tjgb/content/207c7940-dff2-47d9-89dd-cd939acfe4f8.html.2021.05.24.
Nantong Municipal Bureau of Statistics.Nantong seventh national population census bulletin(No.4):population age composition[EB/OL].[2025-09-22].https://tjj.nantong.gov.cn/ntstj/tjgb/content/207c7940-dff2-47d9-89dd-cd939acfe4f8.html.2021.05.24.(in Chinese)
[10] 宁思明,孙宝,晋亚楠,等.1990—2021年中国结直肠癌疾病负担研究及2022—2041年变化趋势分析[J].现代肿瘤医学,2025,33(9):1579-1587.
NING S M,SUN B,JIN Y N,et al.The disease burden of colon and rectum cancer in China from 1990 to 2021 and the predicted trends for 2022—2041[J].J Mod Oncol,2025,33(9):1579-1587.(in Chinese)
[11] 陈奇峰,陈康康,李金,等.2011—2019年绍兴市结直肠癌发病趋势分析[J].预防医学,2021,33(11):1146-1148.
CHEN Q F,CHEN K K,LI J,et al.Incidence trend of colorectal cancer in Shaoxing from 2011 to 2019[J].China Prev Med J,2021,33(11):1146-1148.(in Chinese)
[12] World Cancer Research Fund/American Institute for Cancer Research.The continuous update project expert report2017.Diet,nutrition,physical activity and colorectal cancer[R/OL].[2025-09-22].https://www.wcrf.org/wp-content/uploads/2024/10/Colorectal-cancer-report.pdf.
[13] 高菡璐,俞晓芳,吕乐彬,等.多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J].预防医学,2024,36(3):219-223,227.
GAO H L,YU X F,LYU L B,et al.Interactions of multi-target stool DNA,intestinal flora,carcinoembryonic antigen and fruit intake on the risk of colorectal cancer[J].China Prev Med J,2024,36(3):219-223,227.(in Chinese)
[14] 潘驰,孙晓晖,张增智,等.2014—2020年青岛市居民结直肠癌流行及疾病负担趋势分析[J].中华肿瘤防治杂志,2022,29(20):1439-1445.
PAN C,SUN X H,ZHANG Z Z,et al.Analysis for the trends of colorectal cancer epidemic and disease burden among Qingdao residents from 2014 to 2020[J].Chin J Cancer Prev Treat,2022,29(20):1439-1445.(in Chinese)
[15] 董学思,罗姿麟,雷林,等.男性结直肠癌超额发病风险中已知危险因素的解释效果分析[J].中国肿瘤,2021,30(12):901-904.
DONG X S,LUO Z L,LEI L,et al.Explanatory effects of known risk factors in excess incidence risk of colorectal cancer in men[J].China Cancer,2021,30(12):901-904.(in Chinese)
[16] SPAANDER M C W,ZAUBER A G,SYNGAL S,et al.Young-onset colorectal cancer[J].Nat Rev Dis Primers,2023,9(1):21.
[17] 练佳韦,刘颖春,余红平.结直肠癌的全球流行情况、危险因素及归因疾病负担研究进展[J].中国癌症防治杂志,2024,16(1):1-9.
LIAN J W,LIU Y C,YU H P.Colorectal cancer:global epidemiology,risk factors and advances in attributed disease burden[J].Chin J Oncol Prev Treat,2024,16(1):1-9.(in Chinese)
[18] 国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组.中国结直肠癌筛查与早诊早治指南(2020,北京)[J].中华肿瘤杂志,2021,43(1):16-38.
National Cancer Center,China,Expert Group of the Development of China Guideline for the Screening,Early Detection and Early Treatment of Colorectal Caneer.China guideline for the screening,early detection and early treatment of colorectal cancer(2020 Beijing)[J].Chin J Oncol,2021,43(1):16-38.(in Chinese)
[19] 马昭君,董建梅,柴莉莉,等.2008—2020年江苏省连云港市结直肠癌发病趋势及年龄变化特征分析[J].肿瘤学杂志,2025,31(8):689-696.
MA Z J,DONG J M,CHAI L L,et al.Trends of incidence and age at onset of colorectal cancer in Lianyungang City,Jiangsu Province from 2008 to 2020[J].J Chin Oncol,2025,31(8):689-696.(in Chinese) |
|
|
|
